Vista AI, Inc.

Palo Alto, California

Classification

Private

About

About

HeartVista, Inc. is a pioneering company in the healthcare industry, specializing in AI-driven solutions to enhance cardiac magnetic resonance imaging (MRI). Here is a breakdown of their product/service lines: 1. AI-Enhanced Cardiac MRI Software: - HeartVista's flagship product is advanced AI software designed to optimize and shorten cardiac MR scanning time. - The software utilizes artificial intelligence to improve the efficiency and accuracy of cardiac MRI, providing valuable insights for medical professionals. 2. Collaborative Initiatives with Siemens Healthineers: - HeartVista has collaborated with Siemens Healthineers on initiatives to simplify cardiac MR procedures, showcasing their commitment to industry partnerships and advancements. 3. Expansion Beyond Heart MRIs: - As part of their strategic growth, HeartVista has expressed intentions to expand beyond heart MRIs, reflecting a broader focus on medical imaging and AI applications. HeartVista's dedication to leveraging AI in cardiac imaging positions them as innovators in the field, contributing to the evolution of diagnostic technologies.

Financials

Revenue & Profit

Revenue

Valuation

Valuation

Ratios

Revenue / EBITDA
$123 MM
Valuation / Revenue
$123 MM
Valuation / Employees
$123 MM
EBITDA / Revenue
$123 MM
1-Year CAGR (Revenue)
03
3-Year CAGR (Revenue)
11
1-Year CAGR (Employees)
19
3-Year CAGR (Employees)
96

People

Employee Figures

Employees

Key Executives

NameTitleSocialsEmailPhone
John DoeEmployee
--
Jane DoeEmployee
John DoeEmployee
John DoeEmployee

401K

Total Active Participants
1234
No. Participants with Account Balances
56789
Total Liabilities Start of Year
1234
Total Assets Start of Year
56789

Deals

M&A2024-03-15Completed

Seller

Founders Group

Investor Sponsors

NorthBridge PE

Deal Amount

$120M

Target Company Valuation

$1.20 MM

Techniques

Acquisition of Assets, Taken Private

Stake Tags

100%

Is PE deal

Yes

Is deal PE backed

Yes

Total Acquired

100%

Secondary Transaction2023-09-01Canceled

Target

BrightHealth Technologies

Seller

Early Investors Consortium

Investor Sponsors

--

Deal Amount

Undisclosed

Target Company Valuation

NaN

Techniques

Secondary Sale, Management Buy-out (MBO)

Stake Tags

Majority

Is PE deal

No

Is deal PE backed

Yes

Total Acquired

65%

Funding

Keywords

Keywords

Classified

Private